Breaking News

Thermo Fisher, Qatar Genome Program Partner to Advance Precision Medicine

Includes custom genotyping arrays designed to accelerate genomic research and clinical applications of predictive genomics across Arab populations.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine across Arab populations globally.   Under the agreement, Thermo Fisher and Qatar Genome Program will develop an Axiom custom genotyping array for pan-Arab populations using whole genome sequencing data from 19 Arab countries...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters